These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16213197)

  • 1. Protein kinase structure and function analysis with chemical tools.
    Shen K; Hines AC; Schwarzer D; Pickin KA; Cole PA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):65-78. PubMed ID: 16213197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisubstrate analog probes for the insulin receptor protein tyrosine kinase: molecular yardsticks for analyzing catalytic mechanism and inhibitor design.
    Hines AC; Parang K; Kohanski RA; Hubbard SR; Cole PA
    Bioorg Chem; 2005 Aug; 33(4):285-97. PubMed ID: 16023488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
    Lavogina D; Enkvist E; Uri A
    ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic mechanisms and regulation of protein kinases.
    Wang Z; Cole PA
    Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical approaches to the study of protein tyrosine kinases and their implications for mechanism and inhibitor design.
    Cole PA; Sondhi D; Kim K
    Pharmacol Ther; 1999; 82(2-3):219-29. PubMed ID: 10454199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based design of a protein kinase inhibitor.
    Parang K; Till JH; Ablooglu AJ; Kohanski RA; Hubbard SR; Cole PA
    Nat Struct Biol; 2001 Jan; 8(1):37-41. PubMed ID: 11135668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing bisubstrate analog inhibitors for protein kinases.
    Parang K; Cole PA
    Pharmacol Ther; 2002; 93(2-3):145-57. PubMed ID: 12191607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical approaches to reversible protein phosphorylation.
    Cole PA; Courtney AD; Shen K; Zhang Z; Qiao Y; Lu W; Williams DM
    Acc Chem Res; 2003 Jun; 36(6):444-52. PubMed ID: 12809531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.
    Cozza G; Zanin S; Sarno S; Costa E; Girardi C; Ribaudo G; Salvi M; Zagotto G; Ruzzene M; Pinna LA
    Biochem J; 2015 Nov; 471(3):415-30. PubMed ID: 26349539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling phosphoryl transfer and substrate interactions in protein kinases.
    Lieser SA; Aubol BE; Wong L; Jennings PA; Adams JA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):191-9. PubMed ID: 16213199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of protein kinases and computational prediction of substrates.
    Kobe B; Kampmann T; Forwood JK; Listwan P; Brinkworth RI
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):200-9. PubMed ID: 16172032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.
    Yang J; Cron P; Good VM; Thompson V; Hemmings BA; Barford D
    Nat Struct Biol; 2002 Dec; 9(12):940-4. PubMed ID: 12434148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A.
    Hines AC; Cole PA
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2951-4. PubMed ID: 15125966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in designing substrate-competitive protein kinase inhibitors.
    Han KC; Kim SY; Yang EG
    Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exquisitely specific bisubstrate inhibitors of c-Src kinase.
    Brandvold KR; Santos SM; Breen ME; Lachacz EJ; Steffey ME; Soellner MB
    ACS Chem Biol; 2015 Jun; 10(6):1387-91. PubMed ID: 25793938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical approaches towards unravelling kinase-mediated signalling pathways.
    Hodgson DR; Schröder M
    Chem Soc Rev; 2011 Mar; 40(3):1211-23. PubMed ID: 21152652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Csk phosphorylation and inactivation in vitro by the cAMP-dependent protein kinase.
    Sun G; Ke S; Budde RJ
    Arch Biochem Biophys; 1997 Jul; 343(2):194-200. PubMed ID: 9224730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale proteomics analysis of the human kinome.
    Oppermann FS; Gnad F; Olsen JV; Hornberger R; Greff Z; Kéri G; Mann M; Daub H
    Mol Cell Proteomics; 2009 Jul; 8(7):1751-64. PubMed ID: 19369195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.